Whether the increase in GFAP autoantibody levels in T2D patients reflects elevated plasma GFAP levels or astrocyte activation in the brain is not determined yet, but preclinical studies have shown increased brain GFAP expression in a wide range of different rodent diabetes models [27]. Here, GFAP is linked to diabetes mellitus.